These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Progress in the development of coronavirus disease 2019 vaccine]. Hu LF; Zhu MY; Zhao ZY Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):150-153. PubMed ID: 33548966 [TBL] [Abstract][Full Text] [Related]
6. How to ensure we can track and trace global use of COVID-19 vaccines? Vander Stichele RH; Hay C; Fladvad M; Sturkenboom MCJM; Chen RT Vaccine; 2021 Jan; 39(2):176-179. PubMed ID: 33293161 [No Abstract] [Full Text] [Related]
8. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system. de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines. Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510 [TBL] [Abstract][Full Text] [Related]
10. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2. Hanley BP; Keen S; Church G Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623 [No Abstract] [Full Text] [Related]
11. Rational Vaccine Design in the Time of COVID-19. Burton DR; Walker LM Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707 [TBL] [Abstract][Full Text] [Related]
13. Oxford COVID-vaccine paper highlights lingering unknowns about results. Ledford H Nature; 2020 Dec; 588(7838):378-379. PubMed ID: 33293710 [No Abstract] [Full Text] [Related]
14. Coronavirus vaccines get a biotech boost. Dance A Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847 [No Abstract] [Full Text] [Related]
15. Development of vaccines for SARS-CoV-2. Ng WH; Liu X; Mahalingam S F1000Res; 2020; 9():. PubMed ID: 32850116 [TBL] [Abstract][Full Text] [Related]
16. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. Abu-Raya B; Gantt S; Sadarangani M CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869 [No Abstract] [Full Text] [Related]
17. COVID-19 vaccines: time to talk about the uncertainties. Subbarao K Nature; 2020 Oct; 586(7830):475. PubMed ID: 33082537 [No Abstract] [Full Text] [Related]
18. COVID-19 vaccines for all? Usher AD Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638 [No Abstract] [Full Text] [Related]
19. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19. Coish JM; MacNeil AJ Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062 [TBL] [Abstract][Full Text] [Related]